1. Pagano L, Valentini CG, Pulsoni A, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica. 2013;98(2):239-246. doi:10.3324/haematol.2012.072645 

2. Feuillard J, Jacob M, Falkenrodt A, et al. Clinical and biologic features of CD4+CD56+ malignancies. Blood. 2002;99:1556-1563.

3. Jin X, Li F, Li X, et al. Cutaneous presentation preceding acute monocytic leukemia: A CARE-compliant article. Medicine (Baltimore). 2017;96:e6269-e6269.

4. Kaleem Z, Crawford E, Pathan MH, et al. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data. Arch Patho Lab Med. 2003 Jan;127(1):42-48.

5. Marks JG, Miller JJ. Lookingbill and Marks Principles of Dermatology, 5e. Philadelphia (PA): Elsevier; 2013. p. 115-117

6. Campbell JJ, Clark RA, Watanabe R, et al. Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood. 2010;116:767-771.

7. Harabuchi Y, Takahara M, Kishibe K, et al. Extranodal natural killer/T-cell lymphoma, nasal type: basic science and clinical progress. Front Pediat. 2019 Apr 16;7: 141. https://doi.org/10.3389/fped.2019.00141

8. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissue, Swerdlow SH, Campo E, Harris NL, et al. (Eds), IARC Press, Lyon 2008.

9. Allen P B, Lechowicz MJ. Management of NK/T-cell lymphoma, nasal type. J Oncol Pract. 2019 Oct; 15(10): 513-520.

10. Willemze R, Jansen PM, Cerroni L, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008; 111:838-845.

11. Sweet K. Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment. Curr Opin Hematol. 2020;27(2):103-107. doi:10.1097/MOH.0000000000000569.

12. Aung PP, Sukswai N, Nejati R, Loghavi S, et al. PD1/PD-L1 expression in blastic plasmacytoid dendritic cell neoplasm. Cancers (Basel). 2019 May 19;11(5):695. doi: 10.3390/cancers11050695. PMID: 31109153;

Acknowledgements

Author Profiles

Brittainy Hereford

Penn State Milton S. Hershey Medical Center

Brittainy Hereford, MD, is a PGY-1 transitional year resident at Geisinger Health and incoming dermatology resident at Duke University Health System. She completed her medical degree at the Penn State College of Medicine.

Veronica Merelo Alcocer

Dermatology Physicians, Inc.

Veronica Merelo Alcocer, MD, is a dermatopathologist at Dermatology Physicians, Inc, Lancaster, PA. She received his medical degree and dermatology residency training from the Universidad Nacional Autonoma de Mexico in Mexico City. After completing AP residency at Penn State Milton S. Hershey, Hershey PA, she completed her dermatopathology fellowship at the same institution.

Alexandra Flamm

Penn State Hershey Medical Center

Alexandra Flamm, MD, is a dermatologist and dermatopathologist at Penn State Hershey Medical Center in Hershey, PA, as well as the Dermatology Residency Program Director. She received her medical degree from the Mount Sinai School of Medicine and completed her residency at SUNY Downstate. She then completed her dermatopathology fellowship at the University of Pennsylvania.